Authors: Michael Jacob Adams, Susan G. Fisher, Steven E. Lipshultz, Roy E. Shore, Louis S. Constine, Marilyn Stovall, Ann Dozier, Kelly Thevenet-Morrison, Robert Block, Ronald G. Schwartz and Thomas A. Pearson
The editorial mission of Cardio-Oncology is to advance the science and practice of this emerging field to find a balance between oncologic efficacy and reducing adverse cardiovascular effects through timely publication and dissemination of peer-reviewed research. As an open access, online journal Cardio-Oncology provides a high visibility platform for the publication of original research and expert reviews on the cardiovascular effects of cancer treatment.
The journal welcomes submissions to the following sections: • Adult Oncology - Giuseppe Curigliano and Susan Dent • Clinical Cardiology - Daniela Cardinale and Daniel Lenihan • Clinical Trials - Michael S Ewer and Thomas Suter • Geriatric Oncology - Dawn L Hershman • Imaging - Steven Colan • Nursing - Anecita Fadol and Mary McCabe • Pediatric Oncology - Gregory Armstrong and Stephen E Sallan • Radiation Oncology - Louis Constine • Translational Cardiology - Bonnie Ky and Ed TH Yeh
Editor podcast interview
Cardio-Oncology's Editors, Dr Lipshultz, Dr Carver and Dr Minotti, talk to us about the field – its origins and future, the scale of the problem and how it affects patients.
Steven Lipshultz is the Schotanus Family Professor and Chair of the Carman and Ann Adams Department of Pediatrics at the Wayne State University School of Medicine, as well as the Pediatrician-in-Chief at the Children’s Hospital of Michigan, the Pediatrics Specialist-in-Chief at the Detroit Medical Center, the President of University Pediatricians, and the Interim Director of the Children’s Research Center of Michigan. His primary research interests are in the pediatric cardiomyopathies, especially those of genetic/metabolic, toxic, or infections/inflammatory etiologies.
Joseph Carver, Deputy Editor
Joseph Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, the Chief Operating Officer of the Abramson Family Cancer Research Institute of the Abramson Cancer Center of the University of Pennsylvania and the Chief of Staff of the Abramson Cancer Center.
Giorgio Minotti, Deputy Editor
Giorgio Minotti is Professor of Pharmacology, Head of Drug Sciences and Clinical Pharmacology, Chief of Clinical Trial Center, at the University Campus Bio-Medico of Rome. His research interests focus on pharmacokinetics, pharmacodynamics, and clinical correlates of anticancer drugs cardiovascular toxicity.